ABSTRACT
Antioxidant nutraceuticals such as epigallocatechin 3-gallate, quercetin, and rosmarinic acid have shown potential in the treatment of Parkinson's disease. Many antioxidant nutraceuticals have demonstrated correlation with better health, but due to the many contributing factors more research needs to be conducted to establish causation. Minimal regulation of the nutraceutical market is beneficial to nutraceutical companies by reducing costs, but can potentially be harmful to consumers due to a lack of product research. In the pursuance of taking full advantage of the many potential benefits of nutraceuticals, it is necessary to enforce stricter regulations of products reaching the market. Nutraceuticals have a large global market that is expected to continuously increase as the healthcare system shifts to methods of prevention rather than waiting for the disease onset. The nutraceutical industry has also increased its market growth by appealing to consumers concerned with cancer prevention, as well as brain and cardiovascular health.
